Search

Study described intended to explore practice patterns and continuing education needs for identifying and treating OP, criteria used for testing, and knowledge about OP amongpracticing APNs. An internet survey was administered to APNs nationwide asking fordemographics, OP knowledge and interest, BMD testing patterns, prevention and treatment strategies, and sources used and preferred for continuing education. Data were analyzed using nominal statistics. APNs are actively involved in OP screening, prevention, and treatment. Important areas identified for further education include screening guidelines; medication selection, side effects, and long term effects; and BMD monitoring. Abstract and Poster presented at North American Menopause Society Meeting, October 12- 14, 2006, Nashville, TN.

Osteoporosis and osteopenia are silent processes. Although the Surgeon General has estimated that 44 million Americans have bone loss, the prevalence may be higher. This study was undertaken to identify risk factors and frequency of positive heel scan screenings for osteoporosis and osteopenia in a convenience sample of essentially healthy women attending NP conferences. Implications for women's health: The actual prevalence of low or osteoporotic bone density may be greater than currently estimated. A significant number of participants had low or osteoporotic HBMD screenings, suggesting the need for further testing (eg, DXA). Additionally, despite greater risk factors and older age, fewer NPWH NPs had low or osteoporotic HBMD, perhaps reflecting a protective effect from their higher use of HT and lower use of alcohol and carbonated beverages. Further study is needed to determine the significance of these factors. Abstract and poster presented at the National Association of Nurse Practitioners in Women's Health Meeting, September 28-30, 2006.